U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hypometric upward saccades

MedGen UID:
1645369
Concept ID:
C4703563
Finding
HPO: HP:0031833

Definition

Saccadic undershoot of upward saccadic eye movements, i.e., an upward saccadic eye movement that has less than the magnitude that would be required to gain fixation of the object. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVHypometric upward saccades

Conditions with this feature

Autosomal recessive Parkinson disease 14
MedGen UID:
414488
Concept ID:
C2751842
Disease or Syndrome
Generally, Parkinson's disease that begins after age 50 is called late-onset disease. The condition is described as early-onset disease if signs and symptoms begin before age 50. Early-onset cases that begin before age 20 are sometimes referred to as juvenile-onset Parkinson's disease.\n\nParkinson's disease can also affect emotions and thinking ability (cognition). Some affected individuals develop psychiatric conditions such as depression and visual hallucinations. People with Parkinson's disease also have an increased risk of developing dementia, which is a decline in intellectual functions including judgment and memory.\n\nOften the first symptom of Parkinson's disease is trembling or shaking (tremor) of a limb, especially when the body is at rest. Typically, the tremor begins on one side of the body, usually in one hand. Tremors can also affect the arms, legs, feet, and face. Other characteristic symptoms of Parkinson's disease include rigidity or stiffness of the limbs and torso, slow movement (bradykinesia) or an inability to move (akinesia), and impaired balance and coordination (postural instability). These symptoms worsen slowly over time.\n\nParkinson's disease is a progressive disorder of the nervous system. The disorder affects several regions of the brain, especially an area called the substantia nigra that controls balance and movement.

Recent clinical studies

Therapy

Kobayashi M, Kuwabara S
Eur Neurol 2021;84(2):110-118. Epub 2021 Apr 6 doi: 10.1159/000514246. PMID: 33823506

Prognosis

Nomura Y, Fukuda H, Terao Y, Hikosaka O, Segawa M
Brain Dev 2003 Dec;25 Suppl 1:S48-54. doi: 10.1016/s0387-7604(03)90009-x. PMID: 14980373

Clinical prediction guides

Irving EL, Lillakas L
Exp Eye Res 2019 Jun;183:38-45. Epub 2018 Aug 30 doi: 10.1016/j.exer.2018.08.020. PMID: 30171857
Nomura Y, Fukuda H, Terao Y, Hikosaka O, Segawa M
Brain Dev 2003 Dec;25 Suppl 1:S48-54. doi: 10.1016/s0387-7604(03)90009-x. PMID: 14980373

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...